Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Immanuel Blumenzweig

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of General Virology|February 15, 2001
Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1Nissim Chen, Abraham Morag, Nava Almog, et al.
Virology|November 6, 2004
Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) proteaseMarina Hutoran, Elena Britan, Lea Baraz, et al.
Chembiochem : a European Journal of Chemical Biology|July 9, 2004
Electronic transduction of HIV-1 drug resistance in AIDS patientsLital Alfonta, Immanuel Blumenzweig, Maya Zayats, et al.
Journal of Biomolecular Structure & Dynamics|January 9, 2007
RUN-CBFbeta interaction in C. elegans: computational prediction and experimental verificationOded Suad, Eran Eyal, Immanuel Blumenzweig, et al.
Biochemical and Biophysical Research Communications|April 12, 2002
HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteasesImmanuel Blumenzweig, Lea Baraz, Assaf Friedler, et al.
The Journal of General Virology|August 20, 2002
Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal regionLea Baraz, Marina Hutoran, Immanuel Blumenzweig, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of General Virology|February 15, 2001
Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1Nissim Chen, Abraham Morag, Nava Almog, et al.
Virology|November 6, 2004
Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) proteaseMarina Hutoran, Elena Britan, Lea Baraz, et al.
Chembiochem : a European Journal of Chemical Biology|July 9, 2004
Electronic transduction of HIV-1 drug resistance in AIDS patientsLital Alfonta, Immanuel Blumenzweig, Maya Zayats, et al.
Journal of Biomolecular Structure & Dynamics|January 9, 2007
RUN-CBFbeta interaction in C. elegans: computational prediction and experimental verificationOded Suad, Eran Eyal, Immanuel Blumenzweig, et al.
Biochemical and Biophysical Research Communications|April 12, 2002
HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteasesImmanuel Blumenzweig, Lea Baraz, Assaf Friedler, et al.
The Journal of General Virology|August 20, 2002
Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal regionLea Baraz, Marina Hutoran, Immanuel Blumenzweig, et al.
Pageof 1